Related Experiment Video
Updated: Feb 27, 2026

06:09
Quantification of Proteins Using Peptide Immunoaffinity Enrichment Coupled with Mass Spectrometry
Published on: July 31, 2011
23.6K
Affinity Proteomics for Fast, Sensitive, Quantitative Analysis of Proteins in Plasma
John P O'Grady1, Kevin W Meyer2, Derrick N Poe2
1Perfinity Biosciences, Inc, 1281 Win Hentschel Blvd, West Lafayette, IN, 47906, USA. jogrady@perfinity.com.
Methods in Molecular Biology (Clifton, N.J.)
|July 5, 2017
Summary
This study introduces a rapid workflow for protein enrichment and cleavage, significantly reducing analysis time. The new method accurately quantifies low-abundance biomarkers like Klotho in plasma within 5 hours.
Area of Science:
- Analytical Chemistry
- Biochemistry
- Proteomics
Background:
- Increasingly complex biological samples require sensitive analytical methods.
- Immunoaffinity enrichment is crucial for quantifying low-abundance analytes in proteomics.
- Current enrichment and cleavage protocols are often time-consuming multistep processes.
Purpose of the Study:
- To develop a streamlined workflow for protein enrichment and proteolytic cleavage.
- To reduce the time required for sample preparation in analytical proteomics.
- To enable accurate quantification of low-abundance biomarkers.
Main Methods:
- A novel reactor was designed for integrated protein enrichment and proteolytic cleavage.
- The workflow was validated using Klotho, a low-abundance plasma biomarker.
- Liquid chromatography tandem mass spectrometry (LC-MS/MS) was employed for peptide analysis.
Main Results:
- The integrated workflow significantly reduces sample preparation time.
- Accurate quantification of the low-abundance biomarker Klotho was achieved.
- The entire protocol, from sample to result, can be completed in under 5 hours.
Conclusions:
- The developed single-reactor workflow offers a rapid and efficient approach for proteomic sample preparation.
- This method enhances the ability to analyze complex biological samples and identify biomarkers.
- The protocol facilitates faster biomarker validation and therapeutic efficacy studies.

